Legislators
Bills
Statements
Lobbying
Travel
- Bills
- H.R.806
H.R.806: To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.
About This Bill
- This bill was introduced in the 110th Congress
- This bill is primarily about health
- Introduced Feb. 5, 2007
- Latest Major Action Feb. 5, 2007
- See the four similar bills introduced in other congresses.
Bill Sponsor
Bill Cosponsors
6 (5 Democrats, 2 Republicans)
Bill Summary
Amends the Federal Food, Drug, and Cosmetic Act to prohibit a holder of a new, approved drug application from commencing to manufacture, market, sell, or distribute a generic version of such drug from the time of the receipt of notice from the generic manufacturer that an abbreviated new drug application has been submitted for approval until the expiration or forfeiture of the exclusivity period granted to the generic manufacturer.
(Source: Library of Congress)
Bill Actions
Date | Description |
---|---|
Referred to the House Committee on Energy and Commerce.
|
|
Feb. 5, 2007 |
Introduced in the House by Jo Ann Emerson (R-Mo.) |